EA
TNDM icon

Evolution Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Evolution Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+5
New +$87 ﹤0.01% 833

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Evolution Advisers's TNDM Position: Q2 2026 in Review

Evolution Advisers opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings.

273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Evolution Advisers held 5 shares of Tandem Diabetes Care worth $0 as of Q2 2026.
  • Tandem Diabetes Care was a new Evolution Advisers position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #833 holding.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.